Simplify Asset Management Inc.
Long book
$6.49B
Q1 2026
Positions
142
Top-10 weight
94%
concentration
Last quarter
+3.3%
SPY +14.8%
Turnover
39%
of book per quarter
Strategy in plain words
auto-generated from filingsSimplify Asset Management Inc. is a wealth-management firm allocating client money, specialised in healthcare (63% of the long book), running a $6.49B US long book across 142 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: SIMPLIFY GOVT MNY MRKT ETF, ISHARES CORE S&P 500 ETF, ISHARES CORE U.S. AGGREGATE, SIM ST TREAS FUT STRAT ETF, SIMPLIFY US EQUITY INCOME ET.
Over the last 9 quarters its long book ran on average 2.3pp per quarter behind the S&P 500, beating the index in 2 of 9 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+2.1%
Q2 2024
+5.3%
Q3 2024
-2.4%
Q4 2024
-1.3%
Q1 2025
+7.2%
Q2 2025
+5.1%
Q3 2025
+1.0%
Q4 2025
-0.8%
Q1 2026
+3.3%
Sector allocation
Healthcare 78%
Technology 6%
Materials 6%
Other 3%
Industrials 2%
Financials 2%
Consumer discretionary 1%
Communications 0%
Long book by quarter
What does Simplify Asset own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| UTHR UNITED THERAPEUTICS CORP | Healthcare | 34.3K | $20.3M | 0.3% | +43.7% |
| ALGN ALIGN TECHNOLOGY INC | Healthcare | 106.9K | $18.3M | 0.3% | -0.3% |
| LLY ELI LILLY & CO | Healthcare | 16.7K | $15.4M | 0.2% | -40.3% |
| ABBV ABBVIE INC | Healthcare | 48.6K | $10.6M | 0.2% | +104.5% |
| JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 51.7K | $9.8M | 0.2% | -27.3% |
| PCT PURECYCLE TECHNOLOGIES INC | Materials | 1.8M | $9.2M | 0.1% | -8.4% |
| TMO THERMO FISHER SCIENTIFIC INC | Other | 17.4K | $8.6M | 0.1% | +276.9% |
| GILD GILEAD SCIENCES INC | Healthcare | 61.3K | $8.5M | 0.1% | +63.7% |
| REGN REGENERON PHARMACEUTICALS | Healthcare | 10.9K | $8.4M | 0.1% | -65.0% |
| JNJ JOHNSON & JOHNSON | Healthcare | 33.1K | $8.1M | 0.1% | +50.8% |
| BHVN BIOHAVEN LTD | Healthcare | 898.4K | $7.6M | 0.1% | -6.2% |
| TXG 10X GENOMICS INC-CLASS A | Healthcare | 354.7K | $7.5M | 0.1% | -27.0% |
| MMM 3M CO | Healthcare | 44.2K | $6.4M | 0.1% | +886.4% |
| WRBY WARBY PARKER INC-CLASS A | Healthcare | 290.8K | $6.1M | 0.1% | -27.4% |
| DHR DANAHER CORP | Technology | 32.3K | $6.1M | 0.1% | -27.3% |
| BNTC BENITEC BIOPHARMA INC | Healthcare | 562.2K | $6.0M | 0.1% | +271.9% |
| AMGN AMGEN INC | Healthcare | 15.8K | $5.6M | 0.1% | -69.7% |
| AZN ASTRAZENECA PLC | Healthcare | 25.8K | $5.1M | 0.1% | New |
| ISRG INTUITIVE SURGICAL INC | Healthcare | 10.8K | $5.0M | 0.1% | -27.0% |
| EYPT EYEPOINT INC | Healthcare | 326.1K | $4.2M | 0.1% | -13.1% |
| TSLA TESLA INC | Industrials | 11.1K | $4.1M | 0.1% | -13.6% |
| CVS CVS HEALTH CORP | Healthcare | 54.0K | $3.9M | 0.1% | -27.1% |
| VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 7.9K | $3.5M | 0.1% | -54.6% |
| ACHV ACHIEVE LIFE SCIENCES INC | Materials | 1.2M | $3.5M | 0.1% | Held |
| ALHC ALIGNMENT HEALTHCARE INC | Financials | 193.0K | $3.4M | 0.1% | -26.6% |
| ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 53.0K | $3.0M | 0.0% | -27.3% |
| PHAT PHATHOM PHARMACEUTICALS INC | Healthcare | 262.4K | $2.9M | 0.0% | -18.5% |
| GEHC GE HEALTHCARE TECHNOLOGY | Healthcare | 39.3K | $2.8M | 0.0% | -27.3% |
| DCTH DELCATH SYSTEMS INC | Healthcare | 261.1K | $2.4M | 0.0% | Held |
| ABEO ABEONA THERAPEUTICS INC | Healthcare | 508.0K | $2.3M | 0.0% | +1.5% |
| CLDX CELLDEX THERAPEUTICS INC | Materials | 69.0K | $2.2M | 0.0% | -18.8% |
| GH GUARDANT HEALTH INC | Healthcare | 20.8K | $1.9M | 0.0% | -29.6% |
| MIST MILESTONE PHARMACEUTICALS IN | Healthcare | 1.5M | $1.8M | 0.0% | Held |
| OCS OCULIS HOLDING AG | Healthcare | 66.7K | $1.8M | 0.0% | -32.5% |
| WMT WALMART INC | Consumer discretionary | 14.2K | $1.8M | 0.0% | -8.2% |
| INSM INSMED INC | Healthcare | 10.8K | $1.8M | 0.0% | -70.8% |
| PLTR PALANTIR TECHNOLOGIES INC-A | Technology | 11.7K | $1.7M | 0.0% | +20.2% |
| ABT ABBOTT LABORATORIES | Healthcare | 15.5K | $1.6M | 0.0% | -27.3% |
| CSCO CISCO SYSTEMS INC | Technology | 19.9K | $1.5M | 0.0% | -2.5% |
| LONA LEONABIO INC | Healthcare | 149.3K | $1.5M | 0.0% | Held |
| CORT CORCEPT THERAPEUTICS INC | Healthcare | 37.8K | $1.5M | 0.0% | New |
| KYTX KYVERNA THERAPEUTICS INC | Healthcare | 173.1K | $1.5M | 0.0% | -10.0% |
| PCRX PACIRA BIOSCIENCES INC | Healthcare | 62.7K | $1.4M | 0.0% | -27.4% |
| BRK/B BERKSHIRE HATHAWAY INC-CL B | Financials | 2.6K | $1.3M | 0.0% | New |
| IBM INTL BUSINESS MACHINES CORP | Technology | 4.8K | $1.2M | 0.0% | -1.3% |
| EW EDWARDS LIFESCIENCES CORP | Healthcare | 14.1K | $1.1M | 0.0% | -27.2% |
| VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 56.2K | $1.1M | 0.0% | -45.7% |
| AQST AQUESTIVE THERAPEUTICS INC | Healthcare | 234.3K | $972K | 0.0% | New |
| VOR VOR BIOPHARMA INC | Healthcare | 53.5K | $955K | 0.0% | New |
| ZVRA ZEVRA THERAPEUTICS INC | Healthcare | 100.6K | $938K | 0.0% | +137.5% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Apr 27, 2026 | 143 | $6.52B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 9, 2026 | 142 | $6.13B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 20, 2025 | 129 | $5.43B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 7, 2025 | 89 | $1.99B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 13, 2025 | 94 | $2.67B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 11, 2025 | 92 | $2.02B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR/ARESTATEMENT | Nov 12, 2024 | 106 | $2.15B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 6, 2024 | 107 | $2.15B | SEC ↗ | |
| Q2 2024 | 13F-HR | Aug 12, 2024 | 109 | $1.49B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 13, 2024 | 103 | $1.68B | canonical | SEC ↗ |